Table 1 Blood flow restriction and exercise intervention protocol
| Â | BFR40% + rest* | BFR80% + rest* | BFR40% + LL* | BFR80% + LL* | HIRE + placebo* |
|---|---|---|---|---|---|
BFR application | •40% of the total blood occlusion pressure, bilateral concomitantly. • Time: determined by the average of the BFR + LL group, with a minimum time of 10 min, distributed in series of maximum 5 min of consecutive restriction, and 60 s of rest between series. | •80% of the total blood occlusion pressure, bilateral concomitantly. • Time: determined by the average of the BFR + LL group, with a minimum time of 10 min, distributed in series of maximum 5 min of consecutive restriction, and 60 s of rest between series. | •40% of the total blood occlusion pressure, bilateral concomitantly. •Time: used throughout the exercise period and deflated during rest between sets. | •80% of the total blood occlusion pressure, bilateral concomitantly. •Time: used throughout the exercise period and deflated during rest between sets. | •10% of the total blood occlusion pressure (BFR placebo), bilateral concomitantly. •Time: used throughout the exercise period and deflated during rest between sets. |
Exercise application | • Rest in a sitting position. | • Rest in a sitting position. | • Mode: bilateral knee extension between 90° and 45°. • Load: 30% of 1 RM. • Series: determined by the equivalence of the training volume with the HIRE+placebo group with a maximum number of 15 repetitions per series. •Rest: 60s between sets. | • Mode: bilateral knee extension between 90° and 45°. • Load: 30% of 1 RM. • Series: determined by the equivalence of the training volume with the HIRE+placebo group with a maximum number of 15 repetitions per series. •Rest: 60s between sets. | • Mode: bilateral knee extension between 90° and 45°. • Load: 80% of 1 RM. • Series: 3 series of 8 repetitions. • Rest: 60s between sets. |